healthDemocratic Republic of the Congo
Ebola prevention drug trial enrolls participants in eastern Congo
A trial is testing Gilead’s experimental antiviral obeldesivir in people recently exposed to the Bundibugyo virus. The study is taking place in Ituri province during a major Ebola outbreak.
250participants
More than 250 participants have enrolled in the obeldesivir Ebola prevention trial.